Actelis wins U.S. Marine Corps network modernization order for 65 buildings, valued at about $0.5 million
Bitget2026/10/08 12:32Actelis won a U.S. Marine Corps network modernization purchase order to deploy cyber-hardened VoIP services across 65 buildings. Project investment is estimated at about $0.5 million, covering Actelis equipment plus installation, training, and ongoing support. Rollout targets days by using existing wiring to deliver fiber-grade performance, avoiding new fiber construction across the base. Implementation is being handled by defense integrators HammerTech and Allegiance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actelis Networks Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080830PRIMZONEFULLFEED9842143) on October 08, 2026, and is solely responsible for the information contained therein.
- Actelis won a U.S. Marine Corps network modernization purchase order to deploy cyber-hardened VoIP services across 65 buildings.
- Project investment is estimated at about $0.5 million, covering Actelis equipment plus installation, training, and ongoing support.
- Rollout targets days by using existing wiring to deliver fiber-grade performance, avoiding new fiber construction across the base.
- Implementation is being handled by defense integrators HammerTech and Allegiance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
